Last update 29 Apr 2026

Lactobacillus double live bacteria for vagina(Zhejiang Xinlifei)

Overview

Basic Info

Drug Type
Live biotherapeutic products
Synonyms
XLF 055, XLF-055, XLF055
Target-
Action
modulators
Mechanism
Bacteria replacements, Microbiome modulators
Therapeutic Areas
Infectious DiseasesUrogenital Diseases
Active Indication
Bacterial Vaginosis
Inactive Indication-
Originator Organization
Zhejiang Xinlifei Biotechnology Co., Ltd.
Active Organization
Zhejiang Xinlifei Biotechnology Co., Ltd.
Inactive Organization-
License Organization-
Drug Highest PhasePhase 3
First Approval Date-
Regulation-
Login to view timeline

Related

4
Clinical Trials associated with Lactobacillus double live bacteria for vagina(Zhejiang Xinlifei)
CTR20254340
/ RecruitingPhase 3
评价 XLF055 与甲硝唑联合治疗细菌性阴道病(BV)预防复发的效果及安全性的前瞻性、多中心、随机、双盲、对照的III期临床研究
[Translation] A prospective, multicenter, randomized, double-blind, controlled phase III clinical trial evaluating the efficacy and safety of XLF055 in combination with metronidazole for the prevention of recurrence of bacterial vaginosis (BV).
ChiCTR2500109411
/ Not yet recruitingPhase 3IIT
A prospective, multicenter, randomized, double-blind, controlled phase III clinical study on the efficacy and safety of XLF055 combined with metronidazole in the prevention of recurrence of bacterial vaginosis (BV)
CTR20222591
/ CompletedPhase 2
XLF055多次给药对细菌性阴道病患者的安全性、耐受性及有效性研究
[Translation] Study on the safety, tolerability and efficacy of multiple administrations of XLF055 in patients with bacterial vaginosis
100 Clinical Results associated with Lactobacillus double live bacteria for vagina(Zhejiang Xinlifei)
Login to view more data
100 Translational Medicine associated with Lactobacillus double live bacteria for vagina(Zhejiang Xinlifei)
Login to view more data
100 Patents (Medical) associated with Lactobacillus double live bacteria for vagina(Zhejiang Xinlifei)
Login to view more data
100 Deals associated with Lactobacillus double live bacteria for vagina(Zhejiang Xinlifei)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Bacterial VaginosisPhase 3
China
Zhejiang Xinlifei Biotechnology Co., Ltd.
06 Jan 2026
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free